Abstract
In modern conditions, biomedicine, as a priority sector of the innovation economy, is developing dynamically, due to the desire of the world community to increase the quality of life, duration, financial security, and social well-being. The basis of the structuring of biomedical products is a step-by-step process of transformation of the scientific idea and innovative project into the final product of the industry, having a value assessment and high practical relevance to all stakeholders. One of the criteria of success of an innovative product is the indicator of added value. The aim of the research is to determine the multi-element composition of added value of innovative products in biomedicine and develop its gradual structuring on the basis of a generalization of modern domestic and world level research. The article analyzes the specific structure of biomedicine products, reveals the essence of added value as an indicator integrating assessment and analytical procedures that determine the importance and relevance of a particular biomedical product for the population, government, business community, as well as the degree of need for its early development, approbation, and implementation. A step-by-step structuring of the value added of biomedicine products has been developed and its element-wise composition has been evaluated. Practical significance of which lies in the possibility of making alternative choices at the government level for investment purposes and at the business community level in order to introduce the most promising option from the point of view of mass production and obtaining the maximum socio-economic and financial effect.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Petty, V., Smith, A., Ricardo, D.: Anthology of economic classics, 199 p. (1993)
Alimova, M.S.: Essence and elemental structure of added value. Polythematic Netw. Electron. Sci. J. Kuban State Agrarian Univ. 100, 1423–1433 (2014)
Vasilyev, A.N.: Qualitative preclinical research - the necessary stage of development and introduction into clinical practice of new drugs. Antibiot. Chemother. 57, 41–46 (2012)
Dedkova, E.G.: Communication interaction of elements in the information system of assessment, accounting, analysis and control of cost flows. Manag. Acc. 10, 52–57 (2017)
Krutikov, V.E., Kostina, O.I., Shakhmetova, E.A.: Innovations in the development of the region: cluster of pharmaceuticals, biomedicine and biotechnologies. Bull. Bryansk State Univ. 3, 25–32 (2013)
Marx, K., Engels, F.: Capital. Criticism of political economy. Volume one, 2nd edn., vol. 23, 632 p. (1960)
Malkina, E.L.: Conceptual bases of the theory of cost flows in the framework of the modern understanding of the category “cost”. Manage. Econ. Syst. 10, 25–36 (2016)
Maslov, B.G.: Construction of a model of management accounting of formation of value in the conditions of integrated data processing. Econ. Hum. Sci. 6/212(580), 28–34 (2009)
Maslova, I.A.: The methodology of formation of branch added value and value of products in fair valuation. Manage. Acc. 4, 92–99.4 (2012)
Pankrushina, A.N., Dementieva, S.M., Ivanova, S.A.: The role of biotechnology in the formation of knowledge-based economy. Fundam. Res. 6, 26–35 (2017)
Peshina, E.V., Avdeev, P.A.: Formation of gross added value of high-tech and knowledge-intensive products (goods, services). News UrGEU 6(50), 46–56 (2013)
Starodubov, V.I., Kurakova, N.G.: Financing of medical science: new principles and financial instruments. Health Manager 3, 48–60 (2014)
Honle, T.A.: Expenses for development of innovative drug. Problems of accounting and finance, no. 2(10) (2013). https://cyberleninka.ru/article/n/zatraty-na-razrabotku-innovatsionnogo-lekarstvennogo-preparata
Garina, E.P., Kuznetsova, S.N., Garin, A.P., Romanovskaya, E.V., Andryashina, N.S., Suchodoeva, L.F.: Increasing productivity of complex product of mechanic engineering using modern quality management methods. Acad. Strateg. Manage. J. 16(4), 8 p. (2017)
Frost & Sullivan Review of the market of biotechnology in Russia and assessment of prospects of its development (2014). https://www.rvc.ru/upload/iblock/e21/20141020_Russia_Biotechnology_Market_fin.pdf
Potashnik, Y.S., Garina, E.P., Romanovskaya, E.V., Garin, A.P., Tsymbalov, S.D.: Determining the value of own investment capital of industrial enterprises. Adv. Intell. Syst. Comput. 622, 170–178 (2018)
Yashin, S.N., Trifonov, Y.V., Koshelev, E.V., Garina, E.P., Kuznetsov, V.P.: Evaluation of the effect from organizational innovations of a company with the use of differential cash flow. Adv. Intell. Syst. Comput. 622, 208–216 (2018). https://doi.org/10.1007/978-3-319-75383-6_27
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this paper
Cite this paper
Varaksa, N.G., Alimov, S.A., Alimova, M.S., Konstantinov, V.A. (2020). Structuring the Added Value of Biomedicine Products in the Innovative Economy. In: Popkova, E., Sergi, B. (eds) The 21st Century from the Positions of Modern Science: Intellectual, Digital and Innovative Aspects. ISC 2019. Lecture Notes in Networks and Systems, vol 91. Springer, Cham. https://doi.org/10.1007/978-3-030-32015-7_63
Download citation
DOI: https://doi.org/10.1007/978-3-030-32015-7_63
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-32014-0
Online ISBN: 978-3-030-32015-7
eBook Packages: Intelligent Technologies and RoboticsIntelligent Technologies and Robotics (R0)